Evidence map›Paper›PMID 38202789›Full record

ArticleMolecules (Basel, Switzerland)2023

Reaction of Picolinamides with Ketones Producing a New Type of Heterocyclic Salts with an Imidazolidin-4-One Ring.

Eugenia P Kramarova, Dmitry N Lyakhmun, Dmitry V Tarasenko, Sophia S Borisevich, Edward M Khamitov, Alfia R Yusupova, Alexander A Korlyukov, Alexander R Romanenko, Tatiana A Shmigol, Sergey Yu Bylikin and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Eugenia P KramarovaInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.
Dmitry N LyakhmunInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.
Dmitry V TarasenkoInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.
Sophia S BorisevichUfa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia.
Edward M KhamitovUfa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia.ORCID 0000-0001-8987-4254
Alfia R YusupovaUfa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia.
Alexander A KorlyukovInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.ORCID 0000-0002-5600-9886
Alexander R RomanenkoA.N.Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, Bl. 1, 119334 Moscow, Russia.
Tatiana A ShmigolInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.
Sergey Yu BylikinThe Open University, Walton Hall, Milton Keynes MK7 6BJ, UK.
Yuri I BaukovInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.
Vadim V NegrebetskyInstitute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia.ORCID 0000-0001-6852-8942
Pirogov Russian National Research Medical University · RUUfa Institute of Chemistry · RUA. N. Nesmeyanov Institute of Organoelement Compounds · RUD. Mendeleyev University of Chemical Technology of Russia · RUThe Open University · GB

Funding

Russian Science Foundation 21-73-20250
6 · The paper itself

Abstract

Reactions of picolinamides with 1,3-propanesultone in methanol followed by the treatment with ketones led to a series of previously unknown chemical transformations, yielding first pyridinium salts (

Indexed as

imidazolidin-4-onesNMR and FT-IR spectroscopyquantum-chemical calculationssulfobetainesX-ray study

Identifiers

PMID38202789
PMCPMC10780162
OpenAlexW4390412533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.